The increasing capabilities of computing have changed biology from a realm dominated by scientific discovery to one that intersects with engineering and innovation. Vijay Pande, a General Partner at Andreessen Horowitz, joins Azeem Azhar to discuss the emergence of this novel industry at the interface of technology and biology.
They also discuss:
- The most promising technologies to combat Covid-19 that are being tested.
- Why next-gen biotech companies look increasingly like tech startups.
- Why our long-term health depends on regulators and society engaging with this tech.
If you love what we do, please take a moment to vote for us: British Podcast Awards, Listener’s Choice.
HBR Presents is a network of podcasts curated by HBR editors, bringing you the best business ideas from the leading minds in management. The views and opinions expressed are solely those of the authors and do not necessarily reflect the official policy or position of Harvard Business Review or its affiliates.